Skip to main content
SpringerLink
Log in

When Should IGRT Be Done?

  • Chapter
  • First Online:
Multidisciplinary Management of Rectal Cancer

  • 990 Accesses

Abstract

The therapeutic window of radiotherapy is defined by the balance between the tumor control probability (TCP) and the normal tissue complication probability (NTCP). The tremendous evolution from bony-landmark two-dimensional radiotherapy over CT-based three-dimensional radiotherapy towards highly-conformal radiotherapy techniques such as intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) has broadened the therapeutic window substantially.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. Verellen D, De Ridder M, Linthout N, Tournel K, Soete G, Storme G (2007) Innovations in image-guided radiotherapy. Nat Rev Cancer 7(12):949–960

    Article  CAS  PubMed  Google Scholar 

  2. Jaffray DA (2012) Image-guided radiotherapy: from current concept to future perspectives. Nat Rev Clin Oncol 9(12):688–699

    Article  CAS  PubMed  Google Scholar 

  3. van Herk M, Remeijer P, Rasch C, Lebesque JV (2000) The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 47(4):1121–1135

    Article  PubMed  Google Scholar 

  4. Stroom JC, de Boer HC, Huizenga H, Visser AG (1999) Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. Int J Radiat Oncol Biol Phys 43(4):905–919

    Article  CAS  PubMed  Google Scholar 

  5. Nijkamp J, Swellengrebel M, Hollmann B et al (2012) Repeat CT assessed CTV variation and PTV margins for short- and long-course pre-operative RT of rectal cancer. Radiother Oncol 102(3):399–405

    Article  PubMed  Google Scholar 

  6. Bondar L, Intven M, Burbach JP et al (2014) Statistical modeling of CTV motion and deformation for IMRT of early-stage rectal cancer. Int J Radiat Oncol Biol Phys 90(3):664–672

    Article  PubMed  Google Scholar 

  7. Kasabasić M, Faj D, Ivković A, Jurković S, Belaj N (2010) Rotation of the sacrum during bellyboard pelvic radiotherapy. Med Dosim 35(1):28–30

    Article  PubMed  Google Scholar 

  8. Kim TH, Chie EK, Kim DY, Park SY, Cho KH, Jung KH et al (2005) Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients. Int J Radiat Oncol Biol Phys 62(3):769–775

    Article  PubMed  Google Scholar 

  9. Nijkamp J, Doodeman B, Marijnen C, Vincent A, van Vliet-Vroegindeweij C (2012) Bowel exposure in rectal cancer IMRT using prone, supine, or a belly board. Radiother Oncol 102(1):22–29

    Article  PubMed  Google Scholar 

  10. Nuyttens JJ, Robertson JM, Yan D, Martinez A (2002) The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. Int J Radiat Oncol Biol Phys 53(2):497–503

    Article  PubMed  Google Scholar 

  11. Nijkamp J, de Jong R, Sonke JJ, van Vliet C, Marijnen C (2009) Target volume shape variation during irradiation of rectal cancer patients in supine position: comparison with prone position. Radiother Oncol 93(2):285–292

    Article  PubMed  Google Scholar 

  12. Nijkamp J, de Jong R, Sonke JJ, Remeijer P, van Vliet C, Marijnen C (2009) Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients. Radiother Oncol 92(2):202–209

    Article  PubMed  Google Scholar 

  13. Nijkamp J, Swellengrebel M, Hollmann B et al (2012) Repeat CT assessed CTV variation and PTV margins for short- and long-course pre-operative RT of rectal cancer. Radiother Oncol 102(3):399–405

    Article  PubMed  Google Scholar 

  14. Yan D, Vicini F, Wong J, Martinez A (1997) Adaptive radiation therapy. Phys Med Biol 42:123–132

    Article  CAS  PubMed  Google Scholar 

  15. Nijkamp J, Marijnen C, van Herk M, van Triest B, Sonke JJ (2012) Adaptive radiotherapy for long course neo-adjuvant treatment of rectal cancer. Radiother Oncol 103(3):353–359

    Article  PubMed  Google Scholar 

  16. Maggiulli E, Fiorino C, Passoni P et al (2012) Characterisation of rectal motion during neo-adjuvant radiochemotherapy for rectal cancer with image-guided tomotherapy: implications for adaptive dose escalation strategies. Acta Oncol 51(3):318–324

    Article  PubMed  Google Scholar 

  17. Roels S, Slagmolen P, Nuyts J et al (2008) Biological image-guided radiotherapy in rectal cancer: is there a role for FMISO or FLT, next to FDG? Acta Oncol 47(7):1237–1248

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium

    K. Haustermans & I. Joye

Authors
  1. K. Haustermans
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Joye
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Haustermans .

Editor information

Editors and Affiliations

  1. Dept. of Radiation Oncology, Università Cattolica S Cuore, Rome, Italy

    Vincenzo Valentini

  2. Head, Div. Clinical Oncology Research, University Clinic Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Sachsen-Anhalt, Germany

    Hans-Joachim Schmoll

  3. Department of Surgery, Leiden Univ Med Ctr, Leiden, The Netherlands

    Cornelis J. H. van de Velde

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag Berlin Heidelberg

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Haustermans, K., Joye, I. (2018). When Should IGRT Be Done?. In: Valentini, V., Schmoll, HJ., van de Velde, C. (eds) Multidisciplinary Management of Rectal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-43217-5_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43217-5_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43215-1

  • Online ISBN: 978-3-319-43217-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation